Is XOMA Royalty Corp (XOMAP) Halal?

NASDAQ Healthcare United States N/A
? INSUFFICIENT DATA
Confidence: 0/100
XOMA Royalty Corp (XOMAP) has insufficient data for a complete Shariah compliance screening. This may be due to missing financial statements or incomplete market data.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI N/A N/A N/A N/A ? INSUFFICIENT DATA
DJIM N/A N/A N/A N/A ? INSUFFICIENT DATA
MSCI 53.9%
/ 33%
47.5%
/ 33%
7.7%
/ 33%
33.59%
/ 5%
✗ NOT HALAL
S&P N/A N/A N/A N/A ? INSUFFICIENT DATA
FTSE 53.9%
/ 33%
47.5%
/ 33%
7.7%
/ 50%
33.59%
/ 5%
✗ NOT HALAL

Financial Highlights

P/E Ratio
25.7
EPS
$1.00
Dividend Yield
837.0%
P/B Ratio
3.6
EV/EBITDA
26.1
EV: $375M
Revenue
$10M
Growth: 57.9%
Beta
0.8
Average volatility
Current Ratio
3.4

Profitability

Gross Margin 96.7%
Operating Margin 15.9%
Net Margin 60.8%
Return on Equity (ROE) 34.1%
Return on Assets (ROA) 2.9%

Cash Flow & Balance Sheet

Operating Cash Flow-$14M
Free Cash Flow-$14M
Total Debt$119M
Debt-to-Equity126.5
Current Ratio3.4
Total Assets$221M

Price & Trading

Last Close$25.56
50-Day MA$25.95
200-Day MA$26.16
Avg Volume854
Beta0.8
52-Week Range
$24.96
$30.00

About XOMA Royalty Corp (XOMAP)

CEO
Mr. Owen P. Hughes Jr.
Employees
14
Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
NASDAQ
Currency
USD

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is XOMA Royalty Corp (XOMAP) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), XOMA Royalty Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is XOMA Royalty Corp's debt ratio?

XOMA Royalty Corp's debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 53.9%.

What are XOMA Royalty Corp's key financial metrics?

XOMA Royalty Corp has a market capitalization of N/A, trailing P/E ratio of 25.7, and revenue of $10M. The company maintains a gross margin of 96.7% and a net margin of 60.8%. Return on equity stands at 34.1%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.